Evidence map›Paper›PMID 11320407›Full record

ArticleGene therapy2001

Direct transfection and activation of human cutaneous dendritic cells.

A T Larregina, S C Watkins, G Erdos, L A Spencer, W J Storkus, D Beer Stolz, L D Falo

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. DNA Vaccines-How Far From Clinical Use?International journal of molecular sciences · 2018
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. DNA vaccines for HIV: challenges and opportunities.Springer seminars in immunopathology · 2006
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

A T LarreginaDepartment of Dermatology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
S C Watkins
G Erdos
L A Spencer
W J Storkus
D Beer Stolz
L D Falo
University of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

MEASUREMENT OF T CELL TURNOVER IN SIV INFECTION AND FOLLOWING INTERVENTIONSP01AI043664 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RINALDO, CHARLES R · 1998 to 2006
$3.1M
NIAID NIH HHS P01 AI 43664NIAID NIH HHS R21AI 469701
6 · The paper itself

Abstract

Gene therapy techniques can be important tools for the induction and control of immune responses. Antigen delivery is a critical challenge in vaccine design, and DNA-based immunization offers an attractive method to deliver encoded transgenic protein antigens. In the present study, we used a gene gun to transfect human skin organ cultures with a particular goal of expressing transgenic antigens in resident cutaneous dendritic cells. Our studies demonstrate that when delivered to human skin, gold particles are observed primarily in the epidermis, even when high helium delivery pressures are used. We demonstrate that Langerhans cells resident in the basal epidermis can be transfected, and that biolistic gene delivery is sufficient to stimulate the activation and migration of skin dendritic cells. RT-PCR analysis of dendritic cells, which have migrated from transfected skin, demonstrates the presence of transgenic mRNA, indicating direct transfection of cutaneous dendritic cells. Importantly, transfected epidermal Langerhans cells can efficiently present a peptide derived from the transgenic melanoma antigen MART-1 to a MART-1-specific CTL. Taken together, our results demonstrate direct transfection, activation, and antigen-specific stimulatory function of in situ transduced human Langerhans cells.

Indexed as

TransfectionBiolisticsCell Culture TechniquesCell MovementDendritic CellsEpidermisEpitopesGenetic TherapyGene Transfer TechniquesGoldHumansLangerhans CellsNeoplasm ProteinsReverse Transcriptase Polymerase Chain ReactionSkinT-Lymphocytes, CytotoxicEpitopesGoldMART-1-Melan-A(27-35) epitopeNeoplasm Proteins

Identifiers

PMID11320407
OpenAlexW2331047875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.